Category Archives: Healthcare

Needham Remains a Buy on Medtronic

In a report released today, Michael Matson from Needham reiterated a Buy rating on Medtronic (NYSE: MDT), with a price target of $95. The company’s shares opened today at $85.58. Matson noted: “F4Q17 revenue and EPS beat consensus and initial

ContraFect Gets a Hold Rating from Maxim Group

In a report released today, Jason McCarthy from Maxim Group reiterated a Hold rating on ContraFect (NASDAQ: CFRX). The company’s shares opened today at $1.40, close to its 52-week low of $1.20. McCarthy said: “ContraFect announced that the P2 study

Arch Therapeutics Inc Receives a Buy from Roth Capital

Roth Capital analyst Michael Higgins reiterated a Buy rating on Arch Therapeutics Inc (Other OTC: ARTH) today and set a price target of $3. The company’s shares opened today at $0.50. Higgins wrote: “We met this week with Arch’s CEO

Maxim Group Reaffirms Their Buy Rating on GW Pharma

In a report released today, Gabrielle Zhou from Maxim Group reiterated a Buy rating on GW Pharma (NASDAQ: GWPH), with a price target of $135. The company’s shares opened today at $110.50. Zhou said: “GW pharmaceuticals announced publication of data

Needham Sticks to Its Buy Rating for Aerie Pharma

In a report released today, Serge Belanger from Needham reiterated a Buy rating on Aerie Pharma (NASDAQ: AERI), with a price target of $65. The company’s shares closed yesterday at $40.50. According to TipRanks.com, Belanger is a 2-star analyst with

Maxim Group Remains a Buy on IntelliPharmaCeutics International

Maxim Group analyst Gabrielle Zhou reiterated a Buy rating on IntelliPharmaCeutics International (NASDAQ: IPCI) today and set a price target of $6. The company’s shares closed yesterday at $1.93. Zhou commented: “Intellipharmaceutics announced its marketing partner Par Pharmaceutical has launched